Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

TURKU, FI / ACCESS Newswire / July 9, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - The oral presentation and poster showcase bexmarilimab's dual attack on cancer with new mechanistic data from ...

CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced it will deliver Developing Topics (late-breaking) virtual ...

Manipal Academy of Higher Education (MAHE), Institution of Eminence Deemed to be University, Manipal College of Nursing (MCON), in collaboration with the Faculty of Nursing, University of New ...

The IAEA is inviting professionals in the nuclear field to submit abstracts for its 2026 International Conference on Topical Issues in Nuclear Installation Safety. Known as TIC2026, the conference ...

Poster #4: Pharmacokinetic characterization of buntanetap in plasma of patients with early Alzheimer’s and Parkinson’s diseases. Presenter: Matthew Peterson, Ph.D., Senior Clinical Scientist.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present new findings from patient-focused ...

Home-based cancer care is safe, feasible, and preferred by most patients, according to early findings from a Mayo Clinic ...

Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both ...

Exposure to symptoms of anxiety, depression and headache earlier in life for both children and parents is likely to increase ...

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin ...

ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, June 19, 2025 /PRNewswire/ -- Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the presentation of key ...